Tuesday, 20 Nov 2018


Date Typesort ascending Title Save
04 Nov 2017 Social RT @cgytz: Lumbar mobility is impaired first in SpA. Screen with modified Schober and lateral spinal flexion. #rheumedu #ACR17 https://t.co…
30 Jul 2015 Social PSOLAR registry Infection risk w/ age, DM, smoking, prior Infx, INFLX, ADA. Low rate w/ Stelara 0.83 & ETN 1.47/100PY http://t.co/OxTbxe2HN9
03 Aug 2017 Social FDA Arthritis Advisory Panel votes 10-1 in favor of approving tofacitinib (Xeljanz) for use in Psoriatic athritis. FDA decision pending.
09 Sep 2018 Social Excellent open review of obesity's influence on disease onset (RA, PsA), pathogenesis, disease progression, functional consequences and treatment interference. https://t.co/xaOkBrWDR4
17 Feb 2017 Social RT @DrRachelTate: RAPID3 as a potential useful tool for PsA. Arthur Kavanaugh, MD and Eric Ruderman, MD #rwcs2017 @RWCSmtg @RheumNow https:…
06 Nov 2017 Social Plenary abst#1787 Landawe presents Atlas 5 study, continuation of ADA is assoc w/ signif less flares in nr-AxSpApts… https://t.co/O1xSQ6nafD
22 Oct 2018 Social RT @japaoli19: Abstract 1631 20% incidence of uveitis in SpA with IBD phenotype having the highest incidence #ACR18 @rheumnow https://t.co…
29 Apr 2016 Social Extensive skin psoriasis is a risk factor for Psoriatic Arthritis - other risk factors nail dz, obesity & smoking https://t.co/NZAqi0RJDB
09 Nov 2017 Social RT @japaoli19: @RheumNow Agree. Only 6% were strong recommendations. Glad they addressed comorbidities but management not necessarily consi…
16 Oct 2017 Social Looking at 2 different datasets, having PsA confers a 30+% risk of Cardiovascular dz https://t.co/0OcGOUDg9T
07 Nov 2017 Social RT @DrPetryna: FUTURE5: Cosentyx clinically&radiofraph superior toPBO. mTSS non-progression 88%Cosentyx vs73% PBO #L17 #acr17 @RheumNow htt…
27 Jun 2016 Social RAPID3 gives similar outcome info to BASDAI and ASDAS in a cross sectional study of 85 AS patients https://t.co/uIfXJpB5s3
17 Dec 2017 Social FDA approves Xeljanz (tofacitinib) for use in adults with psoriatic arthritis, alone or in combo w/ MTX/DMARDs. But warns agains combining with biologics, cyclosporine or azathioprine as these have not been studied. https://t.co/ffsAfiaU70
24 Feb 2017 Social Study of >43K Pso, PsA, AS pts shows 14-34% increase risk for depression; but not for suicide or suicidal ideation. https://t.co/STsQikW5pN
13 Jun 2018 Social Lindstrom studied their Swedish AS registry and found that While the presence of Uveitis was assoc w/ better TNFi responses; all other comorbidities yielded lesser TNFi responses. #EULAR2018 @RheumNow OP0023 https://t.co/bltRC4khbL
07 Oct 2016 Social Am I wrong?Otezla warnings overstate risk of depression % wt loss; yet understate diarrhea 9% & D/C for diarrhea <2% https://t.co/UwFi8b6txr
02 Oct 2015 Social Looking at 2 different datasets, having PsA confers a 30+% risk of Cardiovascular dz http://t.co/akU4NR3Etg
08 Nov 2017 Social RT @uptoTate: Increased risk of CVA, but not for MI, in AS pts. #ACR17 @RheumNow #2972 https://t.co/5opG0IudgP https://t.co/8PMXbJY7fq
18 Jun 2015 Social Arthritis mutilans review & defined:digital telescoping/shortening, flail jts, xray resorption, pencil-in-cup change http://t.co/PXq9iPBQyZ
18 Apr 2017 Social Corrona study 1,567 PsA shows patients w/ dactylitis or enthesitis had more Dz activity, Pain, Fatigue, low work,HAQ https://t.co/2UcTOZKhYf